Click here to access Business Weekly's ten year archive of East of England 'Life Sciences' articles
|
|
A third of workforce to go at Cambridge biotech |
|
Written by Lautaro Vargas
|
|
Thursday, 15 May 2008 |
|
One third of the workforce at struggling Cambridge drug discovery firm,
Sareum Holdings, has been laid off in an effort to make the business a
more attractive proposition to potential buyers.
|
|
|
Microsoft in e-health and AIDS hot seat |
|
Written by Tony Quested
|
|
Wednesday, 14 May 2008 |
|
Researchers at Microsoft in Cambridge have lifted the lid on
far-reaching computer technology that could revolutionise key areas of
global healthcare - including improved management of patients' medical
records and the potential development of an AIDS vaccine.
|
|
|
Isogenica takes on cash and makes Finnish acquisition |
|
Written by Lautaro Vargas
|
|
Wednesday, 07 May 2008 |
|
Cambridge based Isogenica has acquired the principal assets of Finnish
biotech company, Karyon CTT Ltd as well as securing a £2 million cash
investment.
|
|
|
Written by Alice Walker
|
|
Friday, 02 May 2008 |
|
Cambridge drug discovery business Sareum Holdings is battling a trading
crisis that could see part or all of the business sold off.
|
|
|
Evans warning to biotech cluster |
|
Written by Alice Walker
|
|
Thursday, 01 May 2008 |
Professor Sir Christopher Evans, chairman of the specialist medical
science investment house, Excalibur, is to tell Cambridge’s biotech
community that they face a ‘Herculean’ task to prove they can weather
the economic downturn that has led to doom-laden assessments of the
sector.
|
|
|
Abcam share price soars on trade update |
|
Written by John Fenton
|
|
Thursday, 01 May 2008 |
Abcam, the Cambridge company that markets antibodies via its own online
catalogue, saw its share price shoot skywards after posting an upbeat
trading update.
|
|
|
Antisoma shifts key London capability to new facility at Hertfordshire BioPark |
|
Written by Lautaro Vargas
|
|
Wednesday, 30 April 2008 |
|
The legacy left by Swiss pharma giant, Roche, in the region continues
with the decision by anti-cancer drug developer, Antisoma, to relocate
its pre and nonclinical operations at the Hertfordshire BioPark in
Welwyn Garden City.
|
|
|
Japanese pharmaceutical firm axeing Cambridge jobs |
|
Written by Lautaro Vargas
|
|
Wednesday, 30 April 2008 |
|
Japanese owned Sosei R & D Ltd could be moving out of Chesterford
Research Park in the search for smaller premises as the company makes
shock redundancies. A company source confirmed it is in the process of axeing several jobs,
though more detailed information couldn’t be given until completion of
a consulting period with staff.
|
|
|
NextGen in talks about sale of UK divisions |
|
Written by Lautaro Vargas
|
|
Wednesday, 30 April 2008 |
|
NextGen Sciences is in talks with a number of companies about the possibility of selling at least one of its three UK divisions following a strategic review that will see the company leave the UK for the US by the end of the year.
|
|
|
Cambridge biotech start-up secures £1million |
|
Written by News Desk
|
|
Thursday, 24 April 2008 |
Cambridge based Domainex, a biopharma spin-out from University College London, has raised £1 million from Longbow Capital LLP, which specialises in healthcare and technology investments, and The Capital Fund.
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 Next > End >>
|
| Results 1 - 20 of 112 |
This Field is required | 
This Field IS visible on profile | 
This Field IS NOT visible on profile | 
Field description: Move mouse over icon
NEWS BY INDUSTRY 